BioDiem Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioDiem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013553
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company’s product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology, used for production of seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies through licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.

BioDiem Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioDiem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BioDiem Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
BioDiem Enters Into Research Agreement With RMIT University For Non-Influenza Vaccines 10
Licensing Agreements 11
BioDiem Enters Into Licensing Agreement With University of Canberra For Hepatitis Vaccine Technology 11
BioDiem Enters Into Licensing Agreement With Australian National University For Infectious Vaccine Technology 12
BioDiem Enters Into Licensing Agreement With Changchun BCHT Biotech For LAIV Vaccine Technology 13
BioDiem Enters Into Licensing Agreement With Serum Institute Of India 14
Equity Offering 15
BioDiem Completes Rights Issue Of Shares For US$2 Million 15
BioDiem Ltd – Key Competitors 16
BioDiem Ltd – Key Employees 17
BioDiem Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Mar 31, 2016: BioDiem Releases Half Year Results 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
BioDiem Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioDiem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioDiem Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BioDiem Enters Into Research Agreement With RMIT University For Non-Influenza Vaccines 10
BioDiem Enters Into Licensing Agreement With University of Canberra For Hepatitis Vaccine Technology 11
BioDiem Enters Into Licensing Agreement With Australian National University For Infectious Vaccine Technology 12
BioDiem Enters Into Licensing Agreement With Changchun BCHT Biotech For LAIV Vaccine Technology 13
BioDiem Enters Into Licensing Agreement With Serum Institute Of India 14
BioDiem Completes Rights Issue Of Shares For US$2 Million 15
BioDiem Ltd, Key Competitors 16
BioDiem Ltd, Key Employees 17
BioDiem Ltd, Subsidiaries 18

★海外企業調査レポート[BioDiem Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • M3 Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary M3 Biotechnology Inc (M3 Biotech) is a clinical stage biotech company that focuses on regenerative medicine. The company is developing clinical programs for the treatment of Alzheimer, MS, Parkinson and Alzheimerdisease (oral) among others. It utilizes discovery platform and develops small m …
  • Thermo Fisher Scientific Inc (TMO)-医療機器分野:企業M&A・提携分析
    Summary Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It also delivers a broad selection of analytical instruments, equipment, consumab …
  • Virtusa Corp (VRTU):企業の財務・戦略的SWOT分析
    Virtusa Corp (VRTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, b …
  • Magma Fincorp Limited:企業のM&A・事業提携・投資動向
    Magma Fincorp Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magma Fincorp Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Bioxyne Ltd (BXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary pro …
  • Shunfeng International Clean Energy Ltd (1165):電力:M&Aディール及び事業提携情報
    Summary Shunfeng International Clean Energy Ltd (Shunfeng International), formerly Shunfeng Photovoltaic International Ltd is a renewable energy company that manufactures and markets solar photovoltaic products. The company’s products include monocrystalline silicon solar cells, polycrystalline sili …
  • Pro-Dex Inc (PDEX):製品パイプライン分析
    Summary Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products comprise motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. Its dental products include DLS handp …
  • Japan Airlines Co Ltd
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務分析
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MolMed SpA (MLM):製薬・医療:M&Aディール及び事業提携情報
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務情報
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • High Peak Royalties Ltd (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Ltd (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nitto Boseki Co Ltd:企業の戦略・SWOT・財務情報
    Nitto Boseki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nitto Boseki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vietnam Dairy Products Joint Stock Co:戦略・SWOT・企業財務分析
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tanzania Electric Supply Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Tanzania Electric Supply Co Ltd (TANESCO), formerly Tanganyika Electric Supply Co Ltd, is a government-owned integrated power company. The company’s operations are regulated by the Ministry of Energy and Minerals. It generates, transmits, distributes and supplies electricity. TANESCO generat …
  • Acarix AS-医療機器分野:企業M&A・提携分析
    Summary Acarix A/S (Acarix) is a medical device company that offers design and development of non-invasive cardiac screening products. The company offers non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score on th …
  • DJO Global Inc:医療機器:M&Aディール及び事業提携情報
    Summary DJO Global Inc. (DJO) is a medical device company. The company engages in provision of orthopaedic devices. DIO develops, manufactures and distributors orthopaedic devices for musculoskeletal health, vascular health and pain management solutions. The company products include rigid and soft o …
  • Zarubezhneft:石油・ガス:M&Aディール及び事業提携情報
    Summary Zarubezhneft is an oil and gas company that explores and develops oil and gas properties. The company constructs, operates and designs oil refineries, tank farms and pipeline systems for storage, transportation and marketing operations. Its services include engineering, design and account ev …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆